Literature DB >> 7664431

Expression and functional significance of tumor necrosis factor receptors in human myocardium.

G Torre-Amione1, S Kapadia, J Lee, R D Bies, R Lebovitz, D L Mann.   

Abstract

BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine with potent negative inotropic properties, is elaborated in septic shock, acute myocarditis, reperfusion injury, and congestive heart failure. TNF-alpha acts by binding to two specific receptors: TNFR1 and TNFR2. However, neither the presence nor the significance of TNF receptors has been studied in the adult mammalian heart. METHODS AND
RESULTS: In the present study, we showed that the adult heart expresses mRNA and receptor proteins for TNFR1 and TNFR2. Moreover, immunohistochemical staining studies localized TNFR1 and TNFR2 to the cardiac myocyte, providing a potential signaling pathway for the deleterious effects of TNF-alpha. The functional significance of the expression of TNFR1 and TNFR2 was explored with the use of a simple cell motion assay in which we assessed the effect(s) of TNF-alpha mutants known to bind selectively to human TNFR1 and TNFR2. We showed that the negative inotropic effect of wild-type TNF-alpha in isolated feline cardiac myocytes was mimicked by the TNF mutant that binds to TNFR1, whereas the TNF mutant that binds to TNFR2 had no significant effect on cell motion.
CONCLUSIONS: Results of the present study show that the adult human heart expresses both mRNA and receptor proteins for TNFR1 and TNFR2; moreover, the negative inotropic effects of TNF-alpha in adult cardiac myocytes appear to be initiated by activation of TNFR1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664431     DOI: 10.1161/01.cir.92.6.1487

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  59 in total

Review 1.  Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

Authors:  G Torre-Amione; S S Stetson; J A Farmer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 3.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

4.  Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure.

Authors:  M Nishino; T Kimura; T Kanda; N Kotajima; A Yoshida; A Kuwabara; K Tamama; Y Fukumura; I Kobayashi
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

Review 5.  The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Authors:  Valentin A Pavlov; Hong Wang; Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

Review 6.  Therapeutic targeting of innate immunity in the failing heart.

Authors:  Veli K Topkara; Sarah Evans; Weili Zhang; Slava Epelman; Lora Staloch; Philip M Barger; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2010-11-10       Impact factor: 5.000

7.  Plasma levels of tumor necrosis factor-alpha and its receptors in patients with mitral stenosis and sinus rhythm undergoing percutaneous balloon valvuloplasty.

Authors:  Kumral Ergun Cagli; Dursun Aras; Serkan Topaloglu; Bilal Geyik; Selime Ayaz; Goksel Cagirci; Halil Lutfi Kisacik; Sule Korkmaz
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

Review 8.  Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.

Authors:  P A Henriksen; D E Newby
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 9.  Heart-brain interactions in mental stress-induced myocardial ischemia.

Authors:  Robert Soufer; Hitender Jain; Andrew J Yoon
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

10.  Dual roles of tumor necrosis factor-alpha receptor-1 in a mouse model of hindlimb ischemia.

Authors:  Jun Jiang; Jianan Wang; Changling Li; Shan Ping Yu; Ling Wei
Journal:  Vasc Med       Date:  2009-02       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.